Bill
SD 1198
Overview: Bill Number: SD 1198, Title: An Act prohibiting discrimination against 340b drug discount program participants, Status: House concurred, Introduced: February 27, 2025, Cl
Overview: Bill Number: SD 1198, Title: An Act prohibiting discrimination against 340b drug discount program participants, Status: House concurred, Introduced: February 27, 2025, Classification: proposed bill
Purpose and Intent: The primary goal of this bill is to protect healthcare providers and patients participating in the 340B Drug Pricing Program, which offers discounted prescription drugs to certain healthcare facilities. The legislation aims to prevent discrimination against these program participants.
Key Provisions:
- Prohibits pharmaceutical manufacturers from denying 340B discounted drugs or imposing restrictions on 340B program participants
- Requires pharmaceutical manufacturers to provide 340B discounted drugs to all eligible healthcare providers without discrimination
- Empowers the state attorney general to investigate and take legal action against any violations
- Allows 340B program participants to seek civil remedies, including damages and injunctive relief, for discriminatory actions
Affected Parties and Impacts:
- Healthcare providers, such as hospitals, clinics, and pharmacies, participating in the 340B program will be protected from discriminatory practices
- Patients who rely on the 340B program for affordable access to prescription drugs will benefit from the increased protections
- Pharmaceutical manufacturers will be required to comply with the new non-discrimination requirements
Procedural and Timeline Considerations:
The bill has been passed by the House and is currently awaiting concurrence in the Senate. If approved, the new anti-discrimination provisions will take effect immediately, providing immediate protection for 340B program participants.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
